Table 1.
Gender | |
---|---|
Female | 5 (41.7) |
Male | 7 (58.3) |
Median (range) age in years | 51 (Range 33–78) |
Eastern Cooperative Oncology Group performance status | |
0 | 2 (16.7) |
1 | 9 (75) |
2 | 1 (8.3) |
Race | |
White | 8 (66.7) |
Asian | 4 (33.3) |
Diagnosis | |
Small cell lung cancer | 3 (25) |
Neuroendocrine prostate cancer | 2 (16.7) |
Colorectal cancer | 2 (16.7) |
Pancreatic cancer | 2 (16.7) |
Neuroendocrine carcinoma of unknown primary | 2 (16.7) |
Adrenocortical carcinoma | 1 (8.3) |
Type of prior therapy | |
Chemotherapy | 12 (100) |
Topoisomerase I inhibitor | 5 (41.7) |
Immunotherapy | 7 (58.3) |
No. of prior systemic treatment | |
1 | 2 (16.7) |
2 | 4 (33.3) |
3 | 3 (25) |
4 | 1 (8.3) |
>4 | 2 (16.7) |